Plant ID: NPO15915
Plant Latin Name: Edgeworthia gardneri
Taxonomy Genus: Edgeworthia
Taxonomy Family: Thymelaeaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
831626-1
India; Nepal; China
GPBAR1; | |
NR1H4; | |
MAPT; LMNA; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Small molecule receptor (family A GPCR) | GPBAR1 | G-protein coupled bile acid receptor 1 | Q8TDU6 | CHEMBL5409 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 1.608E-07 | 1.751E-03 | GPBAR1, NR1H4 |
CC | GO:0043226; organelle | GO:0016607; nuclear speck | 3.503E-03 | 6.872E-01 | LMNA, MAPT |
CC | GO:0044464; cell part | GO:0030673; axolemma | 4.135E-03 | 7.262E-01 | MAPT |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.234E-04 | 1.851E-03 | NR1H4, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 7.230E-03 | 3.041E-02 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 1.145E-02 | 3.041E-02 | CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 1.442E-02 | 3.041E-02 | CYP3A4 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.615E-02 | 3.041E-02 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.713E-02 | 3.041E-02 | CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.812E-02 | 3.041E-02 | CYP3A4 |
09160 Human Diseases | 09165 Cardiovascular diseases | hsa05414 | Dilated cardiomyopathy | 2.230E-02 | 3.041E-02 | LMNA |
09160 Human Diseases | 09165 Cardiovascular diseases | hsa05410 | Hypertrophic cardiomyopathy (HCM) | 2.058E-02 | 3.041E-02 | LMNA |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 2.033E-02 | 3.041E-02 | CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | CYP3A4; |